01549nas a2200217   4500000000100000008004100001260003800042653001200080653001300092653002900105653002400134653004500158100001200203700001100215700001600226700001300242245005400255300001200309520099200321020001801313       2023                            d  bSpringer International Publishing10aScabies10aImpetigo10aMass Drug Administration10aCommunity treatment10aLow- and middle-income countries (LMICs)1 aWelch E1 aYeon J1 aWhitfeld MJ1 aRomani L00aScabies Mass Treatment in Resource-Poor Countries  a419-4313 a<p>An estimated 200 million people worldwide have scabies at any one time. Strategies to manage scabies in endemic settings are needed as most cases occur in resource-poor settings in tropical climates. Scabies is an underrecognised cause of morbidity, and re-infestation can often occur, particularly in crowded settings. When scabies cases are low in a community, treatment is focused on the individual and their household contacts; however, when scabies becomes endemic, treating everyone in the community at once has been shown to be effective. The mass drug administration strategy is currently supported by the World Health Organisation (WHO) to control and eliminate a number of neglected tropical diseases and more recently used as an effective strategy to control scabies (Romani et al., N Engl J Med. 381:186-7, 2019). Mass drug administration for scabies could potentially be administered in combination with other medications to target multiple diseases simultaneously.</p>
  a9783031260698